申请人:Fovea Pharmaceuticals
公开号:EP2570402A1
公开(公告)日:2013-03-20
Bi-aryl derivatives of formula (I), their preparation and their therapeutic application as EP2 agonists in, for example, glaucoma.
or one of its prodrugs, in which:
R1 represents, independently from each other, H or an halogen,
R2 represents H, an halogen, or a (C1-C6)alkyl,
R3 represents, independently from each other, H, an halogen, -OH, or a (C1-C6)alkyl.
式(I)的双芳基衍生物,它们的制备以及它们作为EP2激动剂在治疗青光眼等疾病中的应用。其中:R1分别表示H或卤素,R2表示H、卤素或(C1-C6)烷基,R3分别表示H、卤素、-OH或(C1-C6)烷基。